Biohaven Pharmceuticals (BHVN)

[crudeoil24]

Press Release: Biohaven And Royalty Pharma Announce Royalty Funding And Stock Purchase Agreements Totaling $150 Million
8:06 pm ET June 18, 2018 (Dow Jones) Print
Biohaven And Royalty Pharma Announce Royalty Funding And Stock Purchase Agreements Totaling $150 Million

- Royalty Pharma acquires approximately 2% royalty rights on global annual net sales of rimegepant and BHV-3500 from Biohaven for $100 million

- Royalty participation rate subject to reduction to 1.50% on global annual net sales exceeding $1.5 billion

- Royalty Pharma agrees to acquire 1,111,111 Biohaven common shares for $50 million, at a price of $45.00 per share, representing an approximately 19% premium over the 15-day volume-weighted average price

PR Newswire